A 2003 study split a Xenopus laevis egg extract into portions with different histories. One received calcium to destroy endogenous cyclin B before receiving nondegradable cyclin B; the other received nondegradable cyclin B first, then calcium. The same sustained cyclin B dose was approached from low or high Cdc2 activity. A phosphorimager quantified histone H1 phosphorylation, sampling every – minutes until an apparent stationary response. At –, the dose maintained high activity but failed to induce it from the low state.[ref]
Controls tracked labeled endogenous cyclin B disappearance after calcium treatment and persistence of nondegradable cyclin B, addressing unequal remaining input. The comparison supports hysteresis under extract conditions; finite observations cannot establish indefinite persistence. It does not isolate each reinforcing path or establish thresholds in intact biological cells.[ref]
Histone H1 kinase assay 2026-10-14
A histone H1 kinase assay measures protein kinase action on supplied histone H1, a protein substrate. When the transferred phosphate carries a radioactive isotope label, label incorporated into histone H1 reports catalytic action over the assay interval. It does not count CDK1 molecules, and a crude preparation can contain other protein kinases acting on histone H1. Attribution therefore needs controls.
A 2010 study prepared human HeLa S3 extracts after a double thymidine block, using swelling, a Dounce homogenizer, centrifugation, dialysis and concentration. Added recombinant cyclin B1 incubated for minutes.[ref]
Aliquots received histone H1 and terminal--labeled ATP for a -minute room-temperature reaction, stopped with Laemmli buffer. Dried SDS-PAGE gels exposed a phosphorimager screen; a BioRad Molecular Imager FX quantified labeling. No-added-cyclin B activity set the normalization baseline; RO-3306 reduced H1 activity approximately . Companion Western blots monitored Tyr15 phosphorylation, with actin Western blot loading control.[ref]
Mixed extracts lose compartment boundaries; inhibitor sensitivity supports a major CDK1 contribution, with residual signal.[ref] Substrate choice and inhibitor specificity limit attribution. The cell-cycle hysteresis experiment supplies a separate history comparison with this kind of histone H1 readout; its dose thresholds should not be transferred to human biological cells.
Figure 1.
The histone H1 kinase assay: transferred label, controls and distinct protein measurements
. Original explanatory workflow of the inspected 2010 assay. The -minute extract incubation and -minute assay reaction are separate intervals. No gel lanes or measured intensities are simulated. The no-added-cyclin B baseline and RO-3306 perturbation have different purposes; neither a total-CDK1 Western blot nor a site-specific phosphorylation Western blot replaces the catalytic readout. Details.